C. R. Bard (Murray Hill, New Jersey) said that Jim Beasley has been promoted to group VP with responsibility for the Bard Access Systems and Bard Peripheral Vascular divisions, effective May 1, 2009. Jim joined Bard in 1989 and has been president of Bard Peripheral Vascular since 2007 – a position he will still retain. C.R. Bard makes vascular, oncology and surgical specialty products.

Daniel Hawkins was named VP of global marketing for Endologix (Irvine, California). Hawkins is a founder of Calibra Medical. Endologix makes minimally invasive treatments for aortic disorders.

Maureen Shaffer was named VP of healthcare for Prolifiq Software (Beaverton, Oregon). Most recently, Shaffer was VP of marketing at InSet Technologies. Prolifiq helps sales professionals use digital content in their 1:1 communications with customers and prospects.

Mark Myslinski was named president/CEO of RedPath Integrated Pathology (Pittsburgh). Myslinski has been a Johnson & Johnson executive since 2002 where his responsibilities have included building a new, world-wide Evidence Based Medicine function for the Ortho-Clinical Diagnostics unit. RedPath Integrated Pathology is a genomics-based molecular diagnostics company that provides complex cancer diagnostic testing for pathologists, oncologists and clinicians.

Kim Brodie, RN, was named the director of clinical education and support of Vidacare's (San Antonio) OnControl business unit. Brodie has more than twenty years of experience in hematology and oncology, most recently spending nearly a decade at the University of Texas M.D. Anderson Cancer Center in Houston. Vidacare makes intraosseous access technology for multiple diagnostic, monitoring and therapeutic applications.

No Comments